Results

Total Results: 2,710 records

Showing results for "diabetes screening".
Users also searched for: diabetes guidelines

  1. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1999_SummaryStats_CORE10A.pdf
    January 01, 1999 - PROC W/O CC 30 0.00 294: DIABETES AGE >35 4004 0.56 295: DIABETES AGE 0-35 1651 0.23 296: NUTRITIONAL … 330 0.05 9: Sexually transmitted infections (not HIV or hepatitis) 80 0.01 10: Immunizations and screening … mellitus without complication 320 0.04 50: Diabetes mellitus with complications 8778 1.22 51: Other … 3038 0.42 75: Personal history of mental disorder, mental and behavioral problems, observation and screening … admission 35 0.00 256: Medical examination/evaluation 419 0.06 257: Other aftercare 1081 0.15 258: Other screening
  2. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats_CORE10B.PDF
    January 01, 1998 - PROC W/O CC 30 0.00 294: DIABETES AGE >35 3829 0.56 295: DIABETES AGE 0-35 1448 0.21 296: NUTRITIONAL … 308 0.05 9: Sexually transmitted infections (not HIV or hepatitis) 99 0.01 10: Immunizations and screening … mellitus without complication 218 0.03 50: Diabetes mellitus with complications 8414 1.23 51: Other … 2813 0.41 75: Personal history of mental disorder, mental and behavioral problems, observation and screening … admission 49 0.01 256: Medical examination/evaluation 278 0.04 257: Other aftercare 1316 0.19 258: Other screening
  3. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_1998_SummaryStats.PDF
    January 01, 1998 - PROC W/O CC 257 0.00 294: DIABETES AGE >35 37543 0.55 295: DIABETES AGE 0-35 14847 0.22 296: NUTRITIONAL … 3084 0.05 9: Sexually transmitted infections (not HIV or hepatitis) 1050 0.02 10: Immunizations and screening … mellitus without complication 2173 0.03 50: Diabetes mellitus with complications 83770 1.23 51: Other … 27973 0.41 75: Personal history of mental disorder, mental and behavioral problems, observation and screening … 450 0.01 256: Medical examination/evaluation 3000 0.04 257: Other aftercare 13177 0.19 258: Other screening
  4. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2009_MaskedStats_Core_Weighted.PDF
    January 01, 2009 - PROC W/O CC 135 0.00% 295: DIABETES AGE 0-35 48,074 0.65% 296: NUTRITIONAL & MISC METABOLIC DISORDERS … 2,617 0.04% 9: Sexually transmitted infections (not HIV or hepatitis) 843 0.01% 10: Immunizations and screening … mellitus without complication 9,102 0.12% 50: Diabetes mellitus with complications 40,176 0.55% 51 … 0.01% 256: Medical examination/evaluation 2,814 0.04% 257: Other aftercare 2,031 0.03% 258: Other screening … Substance-related disorders 16,327 0.22% 662: Suicide and intentional self-inflicted injury 387 0.01% 663: Screening
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
    November 01, 2012 - outcomes (mortality, HRQoL [e.g., DLQI, HAQ-DI, EQ-5D] and other patient-reported outcomes, MACE, diabetes … There was insufficient evidence to evaluate myocardial infarction and diabetes mellitus, and no other
  6. www.ahrq.gov/sites/default/files/2025-02/lofland-report.pdf
    January 01, 2025 - Comorbid depression is associated with increased health care use and expenditures in individuals with diabetesDiabetes Care. 2002;25:464-70. (43) Bond Trevor G, Fox Christine M.
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/alternative-payment-models-protocol.pdf
    December 16, 2024 - will be excluded • Outcomes o Change/difference in patient health outcomes (e.g., hypertension, diabetes … emergency department and inpatient utilization [composite outcome], maternal morbidity, hypertension and diabetes … patients with serious mental illness, and patients with medical complexity or chronic diseases such as diabetes
  8. effectivehealthcare.ahrq.gov/sites/default/files/dementia_horizon-scan-high_impact-1306-revised.pdf
    July 09, 2013 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … and nasal spray bottles.44,46,47 Various insulin products already approved for use in patients with diabetes … They thought that the drug’s well-known safety profile and long history of use (in diabetes) would
  9. hcup-us.ahrq.gov/toolssoftware/ccs/AppendixASingleDX.txt
    January 01, 2024 - 09955 09956 09959 0998 0999 79505 79515 79519 79675 79679 10 Immunizations and screening … 2441 2442 2443 2448 2449 2450 2451 2452 2453 2454 2458 2459 2460 2461 2462 2463 2468 2469 7945 49 Diabetes … 7895 78959 7904 7905 7948 V427 152 Pancreatic disorders (not diabetes … V5883 V5889 V589 V660 V665 V666 V667 V669 V670 V6700 V6701 V6709 V6751 V6759 V676 V679 258 Other screening … E9581 E9582 E9583 E9584 E9585 E9586 E9587 E9588 E9589 E959 V6284 663 Screening
  10. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary52/vitamin-d-and-calcium-to-prevent-fractures-preventive-medication-2013
    December 10, 2011 - (RCTs) of generally healthy adults (<20% of study participants had major chronic diseases, such as diabetes … Tufts Evidence-based Practice Center evidence report on vitamin D and calcium 5 , including abstract screening … Albanes D, Purdue MP, Abnet CC, Chatterjee N, et al; Prostate, Lung, Colorectal, and Ovarian Cancer Screening … vitamin D metabolites and breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening
  11. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
    October 01, 2022 - well as full-text reports of titles and abstracts deemed as potentially relevant after the abstract screening … All screening was done in DistillerSR and EndNote was used to track citations. … Following screening, a clinical subject matter expert (SME), a physician specialist, received the list … A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. … the search for guidelines and systematic review returned more than 16,000 potential citations for screening
  13. digital.ahrq.gov/sites/default/files/docs/citation/r21hs024541-goss-final-report-2018.pdf
    January 01, 2018 - "Medication/diabetes medications/oral hypoglycemics/metformin".
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
    September 01, 2014 - search identified 1,521 citations, of which 38 required full-text review after title and abstract screening … anatomical causes such as strictures or prolapsed organs, those with neurologic disorders such as diabetes … requiring an indwelling catheter or clean intermittent catheterization for at least 1 month before screening … Classification: Efficacy Study|Intervention Model: Crossover Assignment|Masking: Open Label|Primary Purpose: Screening … and Symptoms of Overactive Bladder (Urge, Frequency) Device: Interstim therapy NCT01130415 Screening
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment_executive.pdf
    April 01, 2012 - development phase (Figure A) is a modified version of a larger framework depicting the impact of both screening … Analytic framework for screening and treatment of open-angle glaucoma KQ = Key Question; S = Key Questions … for the Comparative Effectiveness of Screening for Glaucoma; T = Key Questions for the Comparative … summarized in the AHRQ report titled Surgical Treatment of Coexisting Cataract and Glaucoma.7 Article Screening … Two reviewers independently applied the same inclusion criteria as used during abstract screening.
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_disposition-comments.pdf
    January 27, 2014 - The research gap portion is much needed and you may want to consider referencing the 1999 American Diabetes … Consensus Development Conference on Diabetic Foot Wound Care 7-9 April 1999 Boston, Massachusetts Diabetes … Margolis have been found useful for diabetes as well as venous disease.
  17. digital.ahrq.gov/sites/default/files/Quartz%20Assessment%20Report_Public%20Version_0.pdf
    August 05, 2024 - regimens is an important reason for inadequate control of chronic diseases such as heart failure, diabetes … What is the effect of mobile phone text message reminders on medication adherence among adult type 2 diabetes … The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence
  18. cdsic.ahrq.gov/sites/default/files/2024-09/Quartz%20Assessment%20Report_Public%20Version_0.pdf
    January 01, 2024 - regimens is an important reason for inadequate control of chronic diseases such as heart failure, diabetes … What is the effect of mobile phone text message reminders on medication adherence among adult type 2 diabetes … The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/fecal-incontinence_research-protocol.pdf
    November 30, 2014 - age, female sex, chronic diarrhea, nerve damage (such as from injury, multiple sclerosis, or chronic diabetes … Citations determined potentially eligible by either investigator will undergo full text screening. … Differences in screening decisions will be resolved by consultation between investigators and a third
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_executive.pdf
    July 01, 2013 - headaches, and irritability.4,22 Decongestants are used with caution, if at all, in patients with diabetes … Overview Of the 4,513 records identified through the literature search, 4,458 were excluded during screening … Systematic Reviews and Meta-Analyses (PRISMA)53 diagram shown in Figure B depicts the flow of search screening